Drew Hillier uses his first-chair experience and background as a former federal law clerk to navigate the most complex intellectual property disputes.

He has a record of success representing Fortune 100, Fortune 500, and other sophisticated clients in patent suits in district courts across the country, as well as before the PTAB, the Judicial Panel on Multidistrict Litigation, and the Federal Circuit. He also represents clients in complex matters involving copyright, the intersection of patent rights with antitrust, unfair trade practices, trade secrets, and licensing.

Drew focuses his practice on patent litigation, with an emphasis on the pharmaceutical, biologic drug, diagnostic equipment, and medical device sectors. Executives and in-house counsel in those fields have entrusted Drew to defend their companies in the most crucial aspects of litigation. Clients regularly rely on Drew, with his extensive courtroom experience, to lead oral argument on high-stakes matters.

Drew is an elected member of the Board of Governors of the Association of Business Trial Lawyers. His achievements have been recognized nationally, including winning The American Lawyer’s Litigator of the Week runner-up honors.

Before clerking in a U.S. district court, Drew graduated first in his class and was editor-in-chief of the Connecticut Law Review at the University of Connecticut, School of Law, which he attended on a full-tuition merit scholarship. He is a Phi Beta Kappa graduate of Saint Louis University, where he earned his B.A. summa cum laude.

Representative Experience

• Won summary judgment in the Southern District of California in a cellular-therapeutics patent infringement case.
• Represented Chugai in patent litigation in the District of Delaware involving Chugai’s revolutionary antibody recycling technology. The team secured a $775 million settlement for Chugai hours before jury selection and opening statements at trial.
• First-chaired a bench trial in an international dispute.
• Defended a pharmaceutical company in a suit involving dozens of patents from seven patent families directed to controlled release and abuse-deterrent dosage forms in the District of Delaware.
• Represented an alleged patent infringer in the District of Connecticut, including winning a motion to dismiss the patentee’s complaint for failure to state a claim and defeating the patentee’s motion to transfer to the Eastern District of Texas.
• Defended a medical device manufacturer in a patent case in the Southern District of California.
• Litigated an inventorship and licensing dispute involving spinal implants to a successful resolution in the Southern District of New York.
• Defended an international law firm in a suit brought by a celebrity rapper involving rights of publicity. The court ultimately ruled in the firm’s favor.
• Litigated a patent infringement dispute over genetic-sample collection devices in the Southern District of California.